Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets

  SEATTLE, WA, July 22, 2022 -- McapMediaWire -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical assets from Wuhan General Group (China), Inc in an all-cash-transaction ("Purchase''). "This purchase is a perfect match to our business model and supports both our strategy in this sector and our direction to continue to create  a path for success for our shareholders," said Kim Halvorson,...

read more

Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update

Conference Call Scheduled for Thursday, December 19th at 4:30 pm ET   South Easton, MA, December 18, 2019 -- – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2019 financial results and to provide a business update (including a discussion of progress made in its development of instrumentation for the nanoemulsification of oil and water, including CBD Oil). Anyone interested may listen to...

read more


Mcap MediaWire - Costumer Service

Translate »